Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
How FDA built a case against CANARX execs offering cheap medication
Suffolk taps array of contech applications on Gilead's new California research center
Court awards Gilead nearly $70M in counterfeit case
Gilead Sciences (NASDAQ:GILD) Insider Johanna Mercier Sells 28,000 Shares of Company Stock
Insider Selling: Gilead Sciences (NASDAQ:GILD) CFO Sells $514,410.00 in Stock
Zacks Research Comments on Gilead Sciences FY2026 Earnings - Stock Observer
Gilead Sciences Maps Growth Beyond BIKTARVY With HIV, Cancer and Inflammation Drugs
Suffolk Celebrates Completion of Gilead Sciences Research Center With Ribbon Cutting
Promising Biotech Stocks To Follow Today - November 17th - Stock Observer
What iShares Biotechnology ETF (IBB) Bought: Gilead Leads on Nov. 13
3,056 Shares of Gilead Sciences, Inc. $GILD Acquired by White Pine Capital LLC - Zolmax
Gilead Sciences Bets on HIV Prevention Growth Despite $1.5 Billion Biktarvy Headwind - Daily Political
Gilead Sciences (GILD) Grants Royalty Free Ebola Drug Licenses For Lower Income Countries
Promising Medical Stocks To Keep An Eye On - November 15th - Stock Observer
Barclays Forecasts Strong Price Appreciation for Gilead Sciences (NASDAQ:GILD) Stock
How South Africa Is Tackling HIV After U.S. Funding Withdrawal
Gilead Sciences, Inc. $GILD Shares Acquired by Bessemer Group Inc.
Zacks Research Cuts Earnings Estimates for Gilead Sciences
Promising Medical Stocks To Keep An Eye On - November 15th - Markets Daily
300,000 Gilead Sciences, Inc. $GILD Shares Sold by Migdal Insurance & Financial Holdings Ltd.
Gilead Sciences, Inc. (NASDAQ:GILD) Stock Has Average Target Price of $171.07 According to Brokerages - Stock Observer
Gilead Sciences, Inc. $GILD Stock: Danske Bank A S Grows Stake
Gilead Sciences, Inc. $GILD Stock: Fisher Asset Management LLC Raises Stake
Gilead Beat the S&P 500 by More Than 25 Points in the Past Year, but $1,000 From a Decade Ago Is Still Worth Less Than $3,500 - 24/7 Wall St.
Gilead Sciences, Inc. $GILD Stake Lifted by Danske Bank A S - Stock Observer
Gilead Sciences (GILD) Wins Bixlenvo Approval With Another FDA Call Due In December
Medical Stocks To Follow Today - November 13th - Stock Observer
Gilead Sciences, Inc. $GILD Stock Position Lifted by Russell Investments Group Ltd.
Gilead (GILD) Stock May Be 44% Undervalued After Lenacapavir News
The Zacks Analyst Blog Highlights Home Depot, Gilead Sciences, TotalEnergies, Key Tronic and iPower
Gilead Sciences (NASDAQ:GILD) EVP Sells $557,809.89 in Stock
Gilead Sciences, Inc. $GILD Stock Sold by Allspring Global Investments Holdings LLC
Gilead Sciences, Inc. $GILD Shares Bought by Lido Advisors LLC - Daily Political
Gilead (GILD) Stock Still Looks Undervalued On Its 205% Run
Gilead Sciences (GILD) Posts PURPOSE 5 Win As HIV Shot Beats Daily Pills
Gilead Sciences (GILD) After Trial Wins And Raised Guidance Looks Fully Valued
Gilead Sciences, Inc. $GILD Stock: Knights of Columbus Asset Advisors LLC Increases Position - Zolmax
Gilead Sciences, Inc. $GILD Shares Acquired by Illinois Municipal Retirement Fund - Stock Observer
Knights of Columbus Asset Advisors LLC Buys 4,617 Shares of Gilead Sciences, Inc. $GILD - Daily Political
Normalized membrane ratio of TROP2 as a predictor of clinical outcomes with datopotamab deruxtecan in non-small-cell lung cancer
Top Medical Stocks To Follow Now - November 10th
Gilead Sciences Targets 200 Treatment Centers for Potential Anito-Cel Launch
Xilio Doses First Patient In XTX501 Cancer Trial; Plans 2027 Data Readout
Gilead Sciences Stock Hits a New All-Time High: Is it Still a Good Buy?
Alps Advisors Inc. Sells 45,008 Shares of Gilead Sciences, Inc. $GILD
Gilead Sciences, Inc. $GILD Stock Bought by M&G PLC - Daily Political
Gilead Sciences (NASDAQ:GILD) Stock: Insider Wettan Keeley Cain Sells 3,399 Shares
Palatin's Peptide Is Advancing Toward the Clinic as Big Pharma Pays Billions for Early Peptides (NASDAQ: PTN)
Insider Selling: Gilead Sciences (NASDAQ:GILD) CEO Sells $17,974,744.04 in Stock - Markets Daily
Elite Wealth Management Inc. Purchases 26,129 Shares of Gilead Sciences, Inc. $GILD - Markets Daily
Elite Wealth Management Inc. Acquires 26,129 Shares of Gilead Sciences, Inc. $GILD
New HIV prevention projects unveiled
Gilead showcases liver disease advances at 9th CIIE
Analyzing Legend Biotech (NASDAQ:LEGN) and Gilead Sciences (NASDAQ:GILD) - Markets Daily
Promising Medical Stocks To Follow Today - November 8th - Markets Daily
3 US Healthcare Dividend Stocks For Higher Rates and Steady Income
Comparing Gilead Sciences (NASDAQ:GILD) and Legend Biotech (NASDAQ:LEGN) - Stock Observer
Gilead Sciences, Inc. $GILD Shares Sold by Pictet Asset Management Holding SA
Ethic Inc. Buys 9,688 Shares of Gilead Sciences, Inc. $GILD
Gilead Sciences, Inc. $GILD Stock: Chicago Partners Investment Group LLC Grows Holdings - Markets Daily
Pictet Asset Management Holding SA Sells 163,821 Shares of Gilead Sciences, Inc. $GILD - Stock Observer
Promising Biotech Stocks To Watch Now - November 5th - Daily Political
Gilead (NASDAQ: GILD) CEO O'Day sells $19.69 million of stock from exercised options - Zolmax
Gilead Sciences, Inc. $GILD Stock Sold by Calamos Advisors LLC
Gilead Pays a $3.28 Annual Dividend Despite Negative Earnings. Is It Safe?
Gilead Sciences (NASDAQ:GILD) CEO Daniel Patrick O'day Sells 102,619 Shares of Stock - Daily Political
Insider Selling: Gilead Sciences (NASDAQ:GILD) CEO Sells 102,619 Shares of Stock
Gilead Sciences (NASDAQ:GILD) CEO Daniel Patrick O'day Sells 9,810 Shares of Stock
Cheap version of game-changing HIV preventive drug granted approval by US authorities
Best Medical Stocks To Add to Your Watchlist - November 6th - Daily Political
Gilead's Livdelzi Achieves 75% ALP Normalization In Phase 3 IDEAL Study; Stock Down
Promising Biotech Stocks To Watch Now - November 5th - Markets Daily
Positive Phase 3 IDEAL Study Results Further Support Livdelzi®'s (Seladelpar) Impact on Achieving ALP Normalization Goals in Second-Line Treatment Across a Broad Population of People Living with Primary Biliary Cholangitis (PBC) | Morningstar
Gilead Sciences (NASDAQ:GILD) Hits New 1-Year High - What's Next?
Gilead Sciences (GILD) Presented 18 Month CAR T Data At ASH 2026
Did Earnings Beat Just Shift Gilead Sciences' (GILD) Investment Narrative?
Gilead Sciences Has Raised Its Dividend for 11 Straight Years. Here's Why the Streak Looks Safe. - AOL
Gilead Sciences, Inc. $GILD Stock Sold by MH & Associates Securities Management Corp ADV
Gilead Sciences, Inc. $GILD Stock: AIA Group Ltd Reduces Stake
Biotech Stocks To Keep An Eye On - November 4th - Markets Daily
Gilead Sciences, Inc. $GILD Stock Purchased by Rakuten Investment Management Inc.
Gilead Sciences, Inc. $GILD Stock Purchased by Provenance Wealth Advisors LLC
Near 52-Week Highs: Is This 88% Margin Biotech Still a Bargain?
Critical Survey: Gilead Sciences (NASDAQ:GILD) versus Xenetic Biosciences (NASDAQ:XBIO) - Stock Observer
BioNTech (BNTX) Enters First Global Phase 3 Trial For New Breast Cancer Combo
Gilead Sciences Sees Unusually High Options Volume (NASDAQ:GILD)
6,170 Shares of Gilead Sciences, Inc. $GILD Bought by TSG Advice Partners LLC
Gilead Sciences, Inc. $GILD Stock Holdings Lifted by BOCHK Asset Management Ltd
Gilead Sciences Launches Global Capability Center in Bengaluru, ETGCC
Insider Selling: Gilead Sciences (NASDAQ:GILD) CEO Sells 15,000 Shares of Stock
Insider Selling: Gilead Sciences (NASDAQ:GILD) CEO Sells 15,881 Shares of Company Stock
Gilead news
Latest news
Show more
Global Market Review: Gold Volatility and Tech Stock Surge Amidst Economic Uncertainty
September CPI Data: Inflation Hurdles, Tariff Impacts, and Fed Rate Cut Expectations
Navigating the AI Boom: Strategies for Investors Amid Nvidia's Valuation Surge
